{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:21:19Z","timestamp":1793830879258,"version":"4.6.1"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,8,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Traditional models used to study lymphoid malignancies, such as 2D cell cultures and murine systems, have significantly advanced our understanding of tumour biology and drug development. However, their limited capacity to recapitulate the tumour microenvironment and 3D anatomical structure restricts their translational relevance. In response to these challenges, three-dimensional (3D) culture systems have recently emerged as promising platforms to more accurately replicate the architecture and biological complexity of lymphoid tissues. A variety of 3D models have been developed, ranging from simple spheroids to advanced organ-on-chip technologies that allow for continuous perfusion and precise modulation of microenvironmental parameters. Current optimisation efforts aim to enhance these systems\u2019 ability to sustain lymphoma cell viability and mimic key in vivo features such as stromal integration, spatial organisation, and biomechanical cues. This review provides an overview of the current 3D models used to investigate mature lymphoid malignancies, with a particular focus on chronic lymphocytic leukaemia and lymphomas. We discuss their relevance, strengths, and limitations, especially in the context of therapeutic screening and the advancement of personalised treatment approaches.<\/jats:p>","DOI":"10.1038\/s41416-026-03487-x","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:53:25Z","timestamp":1780505605000},"page":"336-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Next-generation models for lymphoid malignancies: the rise of 3D culture systems in translational hematology"],"prefix":"10.1038","volume":"135","author":[{"given":"Narim\u00e8ne","family":"Houmera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Genestier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-2783","authenticated-orcid":false,"given":"Sarah","family":"Huet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"3487_CR1","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBDO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia"},{"key":"3487_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13:82.","journal-title":"Blood Cancer J"},{"key":"3487_CR3","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.037366","volume":"11","author":"RE Hynds","year":"2018","unstructured":"Hynds RE, Vladimirou E, Janes SM. The secret lives of cancer cell lines. Dis Model Mech. 2018;11:dmm037366.","journal-title":"Dis Model Mech"},{"key":"3487_CR4","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2144\/000112598","volume":"43","author":"P Hughes","year":"2007","unstructured":"Hughes P, Marshall D, Reid Y, Parkes H, Gelber C. The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques. 2007;43:575-586.","journal-title":"Biotechniques"},{"key":"3487_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.605231","volume":"11","author":"R Foxall","year":"2020","unstructured":"Foxall R, Narang P, Glaysher B, Hub E, Teal E, Coles MC, et al. Developing a 3D B cell lymphoma culture system to model antibody therapy. Front Immunol. 2020;11:605231.","journal-title":"Front Immunol"},{"key":"3487_CR6","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3324\/haematol.12127","volume":"93","author":"J-J Goval","year":"2008","unstructured":"Goval J-J, Thielen C, Bourguignon C, Greimers R, Dejardin E, Choi YS, et al. The prevention of spontaneous apoptosis of follicular lymphoma B cells by a follicular dendritic cell line: involvement of caspase-3, caspase-8 and c-FLIP. Haematologica. 2008;93:1169\u201377.","journal-title":"Haematologica"},{"key":"3487_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-2141.1989.tb04290.x","volume":"71","author":"RJ Collins","year":"1989","unstructured":"Collins RJ, Verschuer LA, Harmon BV, Prentice RL, Pope JH, Kerr JF. Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Haematol. 1989;71:343\u201350.","journal-title":"Br J Haematol"},{"key":"3487_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","volume":"92","author":"P Panayiotidis","year":"1996","unstructured":"Panayiotidis P, Jones D, Ganeshaguru K, Foroni L, Hoffbrand AV. Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol. 1996;92:97\u2013103.","journal-title":"Br J Haematol"},{"key":"3487_CR9","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","volume":"96","author":"JA Burger","year":"2000","unstructured":"Burger JA, Tsukada N, Burger M, Zvaifler NJ, Dell\u2019Aquila M, Kipps TJ. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood. 2000;96:2655\u201363.","journal-title":"Blood"},{"key":"3487_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1288110","volume":"14","author":"B Brauge","year":"2023","unstructured":"Brauge B, Dessauge E, Creusat F, Tarte K. Modeling the crosstalk between malignant B cells and their microenvironment in B-cell lymphomas: challenges and opportunities. Front Immunol. 2023;14:1288110.","journal-title":"Front Immunol"},{"key":"3487_CR11","doi-asserted-by":"crossref","unstructured":"Mossadegh-Keller N, Brisou G, Beyou A, Nadel B, Roulland S. Human B lymphomas reveal their secrets through genetic mouse models. Front Immunol. 2021;12:683597.","DOI":"10.3389\/fimmu.2021.683597"},{"key":"3487_CR12","doi-asserted-by":"publisher","first-page":"a034827","DOI":"10.1101\/cshperspect.a034827","volume":"11","author":"L Pasqualucci","year":"2021","unstructured":"Pasqualucci L, Klein U. Mouse models in the study of mature B-cell malignancies. Cold Spring Harb Perspect Med. 2021;11:a034827.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"3487_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","volume":"20","author":"CH Wong","year":"2019","unstructured":"Wong CH, Siah KW, Lo AW. Estimation of clinical trial success rates and related parameters. Biostatistics. 2019;20:273\u201386.","journal-title":"Biostatistics"},{"key":"3487_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2021.100855","volume":"24","author":"Y Otsuka","year":"2021","unstructured":"Otsuka Y, Kaneko M, Narukawa M. Factors associated with successful phase III trials for solid tumors: a systematic review. Contemp Clin Trials Commun. 2021;24:100855.","journal-title":"Contemp Clin Trials Commun"},{"key":"3487_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.trecan.2020.10.009","volume":"7","author":"J Rodrigues","year":"2021","unstructured":"Rodrigues J, Heinrich MA, Teixeira LM, Prakash J. 3D in vitro model (r)evolution: unveiling tumor\u2013stroma interactions. Trends Cancer. 2021;7:249\u201364.","journal-title":"Trends Cancer"},{"key":"3487_CR16","doi-asserted-by":"publisher","first-page":"889","DOI":"10.3390\/cancers16050889","volume":"16","author":"SW Verbruggen","year":"2024","unstructured":"Verbruggen SW, Freeman CL, Freeman FE. Utilizing 3D models to unravel the dynamics of myeloma plasma cells\u2019 escape from the bone marrow microenvironment. Cancers. 2024;16:889.","journal-title":"Cancers"},{"key":"3487_CR17","doi-asserted-by":"publisher","first-page":"e932","DOI":"10.1097\/HS9.0000000000000932","volume":"7","author":"D Barozzi","year":"2023","unstructured":"Barozzi D, Scielzo C. Emerging strategies in 3D culture models for hematological cancers. HemaSphere. 2023;7:e932.","journal-title":"HemaSphere"},{"key":"3487_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-61779-207-6_8","volume":"769","author":"J Marshall","year":"2011","unstructured":"Marshall J. Transwell\u00ae invasion assays. Methods Mol Biol. 2011;769:97\u2013110.","journal-title":"Methods Mol Biol"},{"key":"3487_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.drudis.2018.02.003","volume":"23","author":"M Mebarki","year":"2018","unstructured":"Mebarki M, Bennaceur A, Bonhomme-Faivre L. Human-cell-derived organoids as a new ex vivo model for drug assays in oncology. Drug Discov Today. 2018;23:857\u201363.","journal-title":"Drug Discov Today"},{"key":"3487_CR20","doi-asserted-by":"crossref","unstructured":"Rasouli M, Safari F, Kanani MH, Ahvati H. Principles of hanging drop method (spheroid formation) in cell culture. In: Turksen, K (ed). Autophagy in development and disease. New York; Springer US, 2024. p. 289\u2013300.","DOI":"10.1007\/7651_2024_527"},{"key":"3487_CR21","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.3389\/fimmu.2019.01943","volume":"10","author":"E Decaup","year":"2019","unstructured":"Decaup E, Rossi C, Gravelle P, Laurent C, Bordenave J, Tosolini M, et al. A tridimensional model for NK cell-mediated ADCC of follicular lymphoma. Front Immunol. 2019;10:1943.","journal-title":"Front Immunol"},{"key":"3487_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.32","volume":"3","author":"E Decaup","year":"2013","unstructured":"Decaup E, Jean C, Laurent C, Gravelle P, Fruchon S, Capilla F, et al. Anti-tumor activity of obinutuzumab and rituximab in a follicular lymphoma 3D model. Blood Cancer J. 2013;3:e131.","journal-title":"Blood Cancer J"},{"key":"3487_CR23","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ajpath.2013.09.018","volume":"184","author":"P Gravelle","year":"2014","unstructured":"Gravelle P, Jean C, Familiades J, Decaup E, Blanc A, Bezombes-Cagnac C, et al. Cell growth in aggregates determines gene expression, proliferation, survival, chemoresistance, and sensitivity to immune effectors in follicular lymphoma. Am J Pathol. 2014;184:282\u201395.","journal-title":"Am J Pathol"},{"key":"3487_CR24","doi-asserted-by":"publisher","first-page":"1554175","DOI":"10.1080\/2162402X.2018.1554175","volume":"8","author":"C Rossi","year":"2019","unstructured":"Rossi C, Gravelle P, Decaup E, Bordenave J, Poupot M, Tosolini M, et al. Boosting \u03b3\u03b4 T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma. Oncoimmunology. 2019;8:1554175.","journal-title":"Oncoimmunology"},{"key":"3487_CR25","doi-asserted-by":"crossref","unstructured":"Gava F, Faria C, Gravelle P, Valero JG, Doba\u00f1o-L\u00f3pez C, Morin R, et al. 3D model characterization by 2D and 3D imaging in t(14;18)-positive B-NHL: perspectives for in vitro drug screens in follicular lymphoma. Cancers. 2021;13:1490.","DOI":"10.3390\/cancers13071490"},{"key":"3487_CR26","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2147\/OTT.S363994","volume":"15","author":"K Du\u015b-Szachniewicz","year":"2022","unstructured":"Du\u015b-Szachniewicz K, Gdesz-Birula K, Rymkiewicz G. Development and characterization of 3D hybrid spheroids for the investigation of the crosstalk between B-cell non-Hodgkin lymphomas and mesenchymal stromal cells. Onco Targets Ther. 2022;15:683\u201397.","journal-title":"Onco Targets Ther"},{"key":"3487_CR27","doi-asserted-by":"publisher","first-page":"e007156","DOI":"10.1136\/jitc-2023-007156","volume":"11","author":"C Faria","year":"2023","unstructured":"Faria C, Gava F, Gravelle P, Valero JG, Doba\u00f1o-L\u00f3pez C, Van Acker N, et al. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine. J Immunother Cancer. 2023;11:e007156.","journal-title":"J Immunother Cancer"},{"key":"3487_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01041-7","volume":"14","author":"C Doba\u00f1o-L\u00f3pez","year":"2024","unstructured":"Doba\u00f1o-L\u00f3pez C, Valero JG, Araujo-Ayala F, Nadeu F, Gava F, Faria C, et al. Patient-derived follicular lymphoma spheroids recapitulate lymph node signaling and immune profile uncovering galectin-9 as a novel immunotherapeutic target. Blood Cancer J. 2024;14:75.","journal-title":"Blood Cancer J"},{"key":"3487_CR29","doi-asserted-by":"publisher","unstructured":"Marcoux P, Gava F, Tosolini M, Gravelle P, Schniederjohann C, Quertinmont S, et al. Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed\/refractory B-NHL. Blood (2026). https:\/\/doi.org\/10.1182\/blood.2025031309.","DOI":"10.1182\/blood.2025031309"},{"key":"3487_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.stem.2024.01.012","volume":"31","author":"JM Kastenschmidt","year":"2024","unstructured":"Kastenschmidt JM, Schroers-Martin JG, Sworder BJ, Sureshchandra S, Khodadoust MS, Liu CL, et al. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment. Cell Stem Cell. 2024;31:410\u2013420.e4.","journal-title":"Cell Stem Cell"},{"key":"3487_CR31","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1016\/j.immuni.2023.06.019","volume":"56","author":"JM Kastenschmidt","year":"2023","unstructured":"Kastenschmidt JM, Sureshchandra S, Jain A, Hernandez-Davies JE, de Assis R, Wagoner ZW, et al. Influenza vaccine format mediates distinct cellular and antibody responses in human immune organoids. Immunity. 2023;56:1910\u20131926.e7.","journal-title":"Immunity"},{"key":"3487_CR32","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41375-023-01885-1","volume":"37","author":"F Araujo-Ayala","year":"2023","unstructured":"Araujo-Ayala F, Doba\u00f1o-L\u00f3pez C, Valero JG, Nadeu F, Gava F, Faria C, et al. A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses. Leukemia. 2023;37:1311\u201323.","journal-title":"Leukemia"},{"key":"3487_CR33","doi-asserted-by":"publisher","first-page":"e938","DOI":"10.1097\/HS9.0000000000000938","volume":"7","author":"MV Haselager","year":"2023","unstructured":"Haselager MV, Van Driel BF, Perelaer E, De Rooij D, Lashgari D, Loos R, et al. In vitro 3D spheroid culture system displays sustained T cell-dependent CLL proliferation and survival. HemaSphere. 2023;7:e938.","journal-title":"HemaSphere"},{"key":"3487_CR34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2424186122","volume":"122","author":"S Mobach","year":"2025","unstructured":"Mobach S, Bergkamp ND, Ma Z, Haselager MV, Anbuhl SM, Jurriens D, et al. Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms. Proc Natl Acad Sci USA. 2025;122:e2424186122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3487_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltaf029","volume":"5","author":"LV Graham","year":"2024","unstructured":"Graham LV, Horehajova L, Haselager MV, Fisher JG, Roos JL, Foxall RB, et al. CD40L and IL-4 suppress NK cell-mediated antibody-dependent cellular cytotoxicity through the HLA-E:NKG2A axis. Immunother Adv. 2024;5:ltaf029.","journal-title":"Immunother Adv"},{"key":"3487_CR36","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1182\/bloodadvances.2020003949","volume":"5","author":"C Lamaison","year":"2021","unstructured":"Lamaison C, Latour S, H\u00e9laine N, Le Morvan V, Saint-Vanne J, Mahouche I, et al. A novel 3D culture model recapitulates primary FL B-cell features and promotes their survival. Blood Adv. 2021;5:5372\u201386.","journal-title":"Blood Adv"},{"key":"3487_CR37","doi-asserted-by":"publisher","first-page":"14843","DOI":"10.1073\/pnas.1309482110","volume":"110","author":"K Alessandri","year":"2013","unstructured":"Alessandri K, Sarangi BR, Gurchenkov VV, Sinha B, Kie\u00dfling TR, Fetler L, et al. Cellular capsules as a tool for multicellular spheroid production and for investigating the mechanics of tumor progression in vitro. Proc Natl Acad Sci USA. 2013;110:14843\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3487_CR38","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1039\/C6LC00133E","volume":"16","author":"K Alessandri","year":"2016","unstructured":"Alessandri K, Feyeux M, Gurchenkov B, Delgado C, Trushko A, Krause K-H, et al. A 3D printed microfluidic device for production of functionalized hydrogel microcapsules for culture and differentiation of human neuronal stem cells. Lab Chip. 2016;16:1593\u2013604.","journal-title":"Lab Chip"},{"key":"3487_CR39","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.18632\/oncotarget.13857","volume":"8","author":"S D\u00e4ster","year":"2017","unstructured":"D\u00e4ster S, Amatruda N, Calabrese D, Ivanek R, Turrini E, Droeser RA, et al. Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment. Oncotarget. 2017;8:1725\u201336.","journal-title":"Oncotarget"},{"key":"3487_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fbioe.2016.00012","volume":"4","author":"ME Katt","year":"2016","unstructured":"Katt ME, Placone AL, Wong AD, Xu ZS, Searson PC. In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol. 2016;4:12.","journal-title":"Front Bioeng Biotechnol"},{"key":"3487_CR41","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/cancers14010190","volume":"14","author":"MAG Barbosa","year":"2021","unstructured":"Barbosa MAG, Xavier CPR, Pereira RF, Petrikait\u0117 V, Vasconcelos MH. 3D cell culture models as recapitulators of the tumor microenvironment for the screening of anti-cancer drugs. Cancers (Basel). 2021;14:190.","journal-title":"Cancers (Basel)"},{"key":"3487_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41591-020-01145-0","volume":"27","author":"LE Wagar","year":"2021","unstructured":"Wagar LE, Salahudeen A, Constantz CM, Wendel BS, Lyons MM, Mallajosyula V, et al. Modeling human adaptive immune responses with tonsil organoids. Nat Med. 2021;27:125\u201335.","journal-title":"Nat Med"},{"key":"3487_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70170","volume":"9","author":"E Lenti","year":"2025","unstructured":"Lenti E, Visentin E, Bojnik E, Neroni A, Franchino M, Talarico D, et al. A spheroid model that recapitulates the protective role of the lymph node microenvironment and serves as a platform for drug testing in chronic lymphocytic leukemia. HemaSphere. 2025;9:e70170.","journal-title":"HemaSphere"},{"key":"3487_CR44","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biomaterials.2018.06.034","volume":"198","author":"A Purwada","year":"2019","unstructured":"Purwada A, Shah SB, B\u00e9guelin W, August A, Melnick AM, Singh A. Ex vivo synthetic immune tissues with T cell signals for differentiating antigen-specific, high affinity germinal center B cells. Biomaterials. 2019;198:27\u201336.","journal-title":"Biomaterials"},{"key":"3487_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202001232","volume":"30","author":"PL Graney","year":"2020","unstructured":"Graney PL, Lai K, Post S, Brito I, Cyster J, Singh A. Organoid polymer functionality and mode of Klebsiella pneumoniae membrane antigen presentation regulates ex vivo germinal center epigenetics in young and aged B cells. Adv Funct Mater. 2020;30:2001232.","journal-title":"Adv Funct Mater"},{"key":"3487_CR46","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41563-023-01495-3","volume":"22","author":"SB Shah","year":"2023","unstructured":"Shah SB, Carlson CR, Lai K, Zhong Z, Marsico G, Lee KM, et al. Combinatorial treatment rescues tumour-microenvironment-mediated attenuation of MALT1 inhibitors in B-cell lymphomas. Nat Mater. 2023;22:511\u201323.","journal-title":"Nat Mater"},{"key":"3487_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.105741","volume":"26","author":"MVJ Braham","year":"2023","unstructured":"Braham MVJ, van Binnendijk RS, Buisman A-MM, Mebius RE, de Wit J, van Els CACM. A synthetic human 3D in vitro lymphoid model enhancing B-cell survival and functional differentiation. iScience. 2023;26:105741.","journal-title":"iScience"},{"key":"3487_CR48","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41563-024-02037-1","volume":"24","author":"Z Zhong","year":"2025","unstructured":"Zhong Z, Qui\u00f1ones-P\u00e9rez M, Dai Z, Juarez VM, Bhatia E, Carlson CR, et al. Human immune organoids to decode B cell response in healthy donors and patients with lymphoma. Nat Mater. 2025;24:297\u2013311.","journal-title":"Nat Mater"},{"key":"3487_CR49","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biomaterials.2015.09.007","volume":"73","author":"YF Tian","year":"2015","unstructured":"Tian YF, Ahn H, Schneider RS, Yang SN, Roman-Gonzalez L, Melnick AM, et al. Integrin-specific hydrogels as adaptable tumor organoids for malignant B and T cells. Biomaterials. 2015;73:110\u20139.","journal-title":"Biomaterials"},{"key":"3487_CR50","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrc727","volume":"2","author":"JD Hood","year":"2002","unstructured":"Hood JD, Cheresh DA. Role of integrins in cell invasion and migration. Nat Rev Cancer. 2002;2:91\u2013100.","journal-title":"Nat Rev Cancer"},{"key":"3487_CR51","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1182\/blood-2014-07-587337","volume":"125","author":"F Cayrol","year":"2015","unstructured":"Cayrol F, D\u00edaz Flaqu\u00e9 MC, Fernando T, Yang SN, Sterle HA, Bolontrade M, et al. Integrin \u03b1v\u03b23 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells. Blood. 2015;125:841\u201351.","journal-title":"Blood"},{"key":"3487_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202008400","volume":"31","author":"LC Bahlmann","year":"2021","unstructured":"Bahlmann LC, Baker AEG, Xue C, Liu S, Meier-Merziger M, Karakas D, et al. Gelatin\u2013hyaluronan click-crosslinked cryogels elucidate human macrophage invasion behavior. Adv Funct Mater. 2021;31:2008400.","journal-title":"Adv Funct Mater"},{"key":"3487_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122121","volume":"297","author":"LC Bahlmann","year":"2023","unstructured":"Bahlmann LC, Xue C, Chin AA, Skirzynska A, Lu J, Th\u00e9riault B, et al. Targeting tumour-associated macrophages in Hodgkin lymphoma using engineered extracellular matrix-mimicking cryogels. Biomaterials. 2023;297:122121.","journal-title":"Biomaterials"},{"key":"3487_CR54","doi-asserted-by":"publisher","DOI":"10.1126\/science.ade8520","volume":"384","author":"J Zak","year":"2024","unstructured":"Zak J, Pratumchai I, Marro BS, Marquardt KL, Zavareh RB, Lairson LL, et al. JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma. Science. 2024;384:eade8520.","journal-title":"Science"},{"key":"3487_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.639572","volume":"12","author":"FV Sbrana","year":"2021","unstructured":"Sbrana FV, Pinos R, Barbaglio F, Ribezzi D, Scagnoli F, Scarf\u00f2 L, et al. 3D bioprinting allows the establishment of long-term 3D culture model for chronic lymphocytic leukemia cells. Front Immunol. 2021;12:639572.","journal-title":"Front Immunol"},{"key":"3487_CR56","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/jbm.a.36031","volume":"105","author":"FNU Apoorva","year":"2017","unstructured":"Apoorva FNU, Tian YF, Pierpont TM, Bassen DM, Cerchietti L, Butcher JT, et al. Lymph node stiffness-mimicking hydrogels regulate human B-cell lymphoma growth and cell surface receptor expression in a molecular subtype-specific manner. J Biomed Mater Res A. 2017;105:1833\u201344.","journal-title":"J Biomed Mater Res A"},{"key":"3487_CR57","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal JT, Li X, Zhu J, Giangarra V, Grzeskowiak CL, Ju J, et al. Organoid modeling of the tumor immune microenvironment. Cell. 2018;175:1972\u20131988.e16.","journal-title":"Cell"},{"key":"3487_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55098-w","volume":"15","author":"A Santamaria-Mart\u00ednez","year":"2024","unstructured":"Santamaria-Mart\u00ednez A, Epiney J, Srivastava D, Tavernari D, Varrone M, Milowich D, et al. Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening. Nat Commun. 2024;15:10650.","journal-title":"Nat Commun"},{"key":"3487_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster MA, Knoblich JA. Organogenesis in a dish: modeling development and disease using organoid technologies. Science. 2014;345:1247125.","journal-title":"Science"},{"key":"3487_CR60","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1038\/s41375-025-02562-1","volume":"39","author":"S Li","year":"2025","unstructured":"Li S, Ren J, Wu J, Xia Z, Li Y, Li C, et al. Establishment and molecular characterisation of patient-derived organoids for primary central nervous system lymphoma. Leukemia. 2025;39:1169\u201383.","journal-title":"Leukemia"},{"key":"3487_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41568-018-0104-6","volume":"19","author":"A Sontheimer-Phelps","year":"2019","unstructured":"Sontheimer-Phelps A, Hassell BA, Ingber DE. Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019;19:65\u201381.","journal-title":"Nat Rev Cancer"},{"key":"3487_CR62","doi-asserted-by":"publisher","first-page":"5409","DOI":"10.1039\/D2AN01344D","volume":"147","author":"C Watson","year":"2022","unstructured":"Watson C, Liu C, Ansari A, Miranda HC, Somoza RA, Senyo SE. Multiplexed microfluidic chip for cell co-culture. Analyst. 2022;147:5409\u201318.","journal-title":"Analyst"},{"key":"3487_CR63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1039\/C6LC01204C","volume":"17","author":"RG Mannino","year":"2017","unstructured":"Mannino RG, Santiago-Miranda AN, Pradhan P, Qiu Y, Mejias JC, Neelapu SS, et al. 3D microvascular model recapitulates the diffuse large B-cell lymphoma tumor microenvironment in vitro. Lab Chip. 2017;17:407\u201314.","journal-title":"Lab Chip"},{"key":"3487_CR64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3109\/10428190109057978","volume":"41","author":"Y Aoki","year":"2001","unstructured":"Aoki Y, Tosato G. Vascular endothelial growth factor\/vascular permeability factor in the pathogenesis of primary effusion lymphomas. Leuk Lymphoma. 2001;41:229\u201337.","journal-title":"Leuk Lymphoma"},{"key":"3487_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo3826","volume":"15","author":"C Mastini","year":"2023","unstructured":"Mastini C, Campisi M, Patrucco E, Mura G, Ferreira A, Costa C, et al. Targeting CCR7\u2013PI3K\u03b3 overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma. Sci Transl Med. 2023;15:eabo3826.","journal-title":"Sci Transl Med"},{"key":"3487_CR66","first-page":"362326","volume":"2011","author":"CE Caicedo-Carvajal","year":"2011","unstructured":"Caicedo-Carvajal CE, Liu Q, Remache Y, Goy A, Suh KS. Cancer tissue engineering: a novel 3D polystyrene scaffold for in vitro isolation and amplification of lymphoma cancer cells from heterogeneous cell mixtures. J Tissue Eng. 2011;2011:362326.","journal-title":"J Tissue Eng"},{"key":"3487_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.947823","volume":"12","author":"J Ceccato","year":"2022","unstructured":"Ceccato J, Piazza M, Pizzi M, Manni S, Piazza F, Caputo I, et al. A bone-based 3D scaffold as an in-vitro model of microenvironment\u2013DLBCL lymphoma cell interaction. Front Oncol. 2022;12:947823.","journal-title":"Front Oncol"},{"key":"3487_CR68","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.3324\/haematol.2020.248112","volume":"106","author":"F Barbaglio","year":"2021","unstructured":"Barbaglio F, Belloni D, Scarf\u00f2 L, Sbrana FV, Ponzoni M, Bongiovanni L, et al. Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents. Haematologica. 2021;106:2334\u201344.","journal-title":"Haematologica"},{"key":"3487_CR69","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI24276","volume":"115","author":"C Scielzo","year":"2005","unstructured":"Scielzo C, Ghia P, Conti A, Bachi A, Guida G, Geuna M, et al. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses. J Clin Invest. 2005;115:1644\u201350.","journal-title":"J Clin Invest"},{"key":"3487_CR70","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1182\/blood-2009-12-258814","volume":"116","author":"C Scielzo","year":"2010","unstructured":"Scielzo C, Bertilaccio MTS, Simonetti G, Dagklis A, ten Hacken E, Fazi C, et al. HS1 has a central role in the trafficking and homing of leukemic B cells. Blood. 2010;116:3537\u201346.","journal-title":"Blood"},{"key":"3487_CR71","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.052731","author":"D Belloni","year":"2026","unstructured":"Belloni D, Barozzi D, Milani G, Barbaglio F, Aswin PR, Ranghetti P, et al. A 3D lymph node model for chronic lymphocytic leukaemia recapitulates microenvironmental features and drug response in vitro. Dis Model Mech. 2026. https:\/\/doi.org\/10.1242\/dmm.052731.","journal-title":"Dis Model Mech"},{"key":"3487_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2025.101105","volume":"5","author":"D Barozzi","year":"2025","unstructured":"Barozzi D, Scagnoli F, Barbaglio F, Belloni D, Ribezzi D, Far\u00e8 S, et al. Dynamic stimulation promotes functional tissue-like organization of a 3D human lymphoid microenvironment model in vitro. Cell Rep Methods. 2025;5:101105.","journal-title":"Cell Rep Methods"},{"key":"3487_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2024.115485","volume":"217","author":"C Mazzaglia","year":"2025","unstructured":"Mazzaglia C, Huang YYS, Shields JD. Advancing tumor microenvironment and lymphoid tissue research through 3D bioprinting and biofabrication. Adv Drug Deliv Rev. 2025;217:115485.","journal-title":"Adv Drug Deliv Rev"},{"key":"3487_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s40824-023-00457-9","volume":"27","author":"DM Alhattab","year":"2023","unstructured":"Alhattab DM, Isaioglou I, Alshehri S, Khan ZN, Susapto HH, Li Y, et al. Fabrication of a three-dimensional bone marrow niche-like acute myeloid leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system. Biomater Res. 2023;27:111.","journal-title":"Biomater Res"},{"key":"3487_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202100884","volume":"11","author":"D Wu","year":"2022","unstructured":"Wu D, Wang Z, Li J, Song Y, Perez MEM, Wang Z, et al. A 3D-bioprinted multiple myeloma model. Adv Healthc Mater. 2022;11:2100884.","journal-title":"Adv Healthc Mater"},{"key":"3487_CR76","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tcb.2006.11.007","volume":"17","author":"JM Rutkowski","year":"2007","unstructured":"Rutkowski JM, Swartz MA. A driving force for change: interstitial flow as a morphoregulator. Trends Cell Biol. 2007;17:44\u201350.","journal-title":"Trends Cell Biol"},{"key":"3487_CR77","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.canlet.2019.01.043","volume":"449","author":"D Karami","year":"2019","unstructured":"Karami D, Richbourg N, Sikavitsas V. Dynamic in vitro models for tumor tissue engineering. Cancer Lett. 2019;449:178\u201385.","journal-title":"Cancer Lett"},{"key":"3487_CR78","doi-asserted-by":"publisher","DOI":"10.1063\/5.0146000","volume":"7","author":"Y Juste-Lanas","year":"2023","unstructured":"Juste-Lanas Y, Hervas-Raluy S, Garc\u00eda-Aznar JM, Gonz\u00e1lez-Loyola A. Fluid flow to mimic organ function in 3D in vitro models. APL Bioeng. 2023;7:031501.","journal-title":"APL Bioeng"},{"key":"3487_CR79","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s41423-023-01042-9","volume":"20","author":"V Angeli","year":"2023","unstructured":"Angeli V, Lim HY. Biomechanical control of lymphatic vessel physiology and functions. Cell Mol Immunol. 2023;20:1051\u201362.","journal-title":"Cell Mol Immunol"},{"key":"3487_CR80","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1349-7006.2012.02289.x","volume":"103","author":"Y Kawai","year":"2012","unstructured":"Kawai Y, Kaidoh M, Yokoyama Y, Ohhashi T. Pivotal roles of shear stress in the microenvironmental changes that occur within sentinel lymph nodes. Cancer Sci. 2012;103:1245\u201352.","journal-title":"Cancer Sci"},{"key":"3487_CR81","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/lrb.2009.0015","volume":"7","author":"JW Breslin","year":"2009","unstructured":"Breslin JW, Kurtz KM. Lymphatic endothelial cells adapt their barrier function in response to changes in shear stress. Lymphat Res Biol. 2009;7:229\u201337.","journal-title":"Lymphat Res Biol"},{"key":"3487_CR82","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1007\/s10237-024-01879-7","volume":"23","author":"A Girelli","year":"2024","unstructured":"Girelli A, Giantesio G, Musesti A, Penta R. Multiscale computational analysis of the steady fluid flow through a lymph node. Biomech Model Mechanobiol. 2024;23:2005\u201323.","journal-title":"Biomech Model Mechanobiol"},{"key":"3487_CR83","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.celrep.2018.03.069","volume":"23","author":"F Apoorva","year":"2018","unstructured":"Apoorva F, Loiben AM, Shah SB, Purwada A, Fontan L, Goldstein R, et al. How biophysical forces regulate human B cell lymphomas. Cell Rep. 2018;23:499\u2013511.","journal-title":"Cell Rep"},{"key":"3487_CR84","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1182\/blood-2013-12-544569","volume":"123","author":"E Walsby","year":"2014","unstructured":"Walsby E, Buggins A, Devereux S, Jones C, Pratt G, Brennan P, et al. Development and characterization of a physiologically relevant model of lymphocyte migration in chronic lymphocytic leukemia. Blood. 2014;123:3607\u201317.","journal-title":"Blood"},{"key":"3487_CR85","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1039\/D5LC00875A","volume":"26","author":"Y Peng","year":"2026","unstructured":"Peng Y, Lee E. Lymphatics-on-a-chip microphysiological system: engineering lymphatic structure and function in vitro. Lab Chip. 2026;26:1588\u2013609.","journal-title":"Lab Chip"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03487-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03487-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:03:14Z","timestamp":1784109794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03487-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8,5]]}},"alternative-id":["3487"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03487-x","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}